Cargando…

Heterologous vaccine therapy associated with half course of Miltefosine promote activation of the proinflammatory response with control of splenic parasitism in a hamster model of visceral leishmaniasis

Visceral leishmaniasis (VL) is a serious and neglected disease present worldwide. Chemotherapy using pentavalent antimony (Sb(V)) is the most practical and inexpensive strategy available for the VL treatment today, however, it has high toxicity. Alternatively, other drugs are used as viable leishman...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carvalho, Lívia Mendes, Ferreira, Francielle Carvalho, Gusmão, Miriã Rodrigues, Costa, Ana Flávia Pereira, de Brito, Rory Cristiane Fortes, Aguiar-Soares, Rodrigo Dian de Oliveira, Reis, Alexandre Barbosa, Cardoso, Jamille Mirelle de Oliveira, Carneiro, Cláudia Martins, Roatt, Bruno Mendes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040144/ https://www.ncbi.nlm.nih.gov/pubmed/35492387 http://dx.doi.org/10.1016/j.crimmu.2021.10.003

Ejemplares similares

Liver infusion tryptose (LIT): the best choice for growth, viability, and infectivity of Leishmania infantum parasites
por: Costa, Ana Flávia Pereira, et al.
Publicado: (2020)

Synthetic Peptides Elicit Strong Cellular Immunity in Visceral Leishmaniasis Natural Reservoir and Contribute to Long-Lasting Polyfunctional T-Cells in BALB/c Mice
por: De Brito, Rory Cristiane Fortes, et al.
Publicado: (2019)

Phase I and II Clinical Trial Comparing the LBSap, Leishmune(®), and Leish-Tec(®) Vaccines against Canine Visceral Leishmaniasis
por: Aguiar-Soares, Rodrigo Dian de Oliveira, et al.
Publicado: (2020)

The Use of an Adjuvant System Improves Innate and Adaptive Immune Response When Associated with a Leishmania (Viannia) braziliensis Antigen in a Vaccine Candidate against L. (Leishmania) infantum Infection
por: Mathias, Fernando Augusto Siqueira, et al.
Publicado: (2023)

Parasite Burden in Hamsters Infected with Two Different Strains of Leishmania (Leishmania) infantum: “Leishman Donovan Units” versus Real-Time PCR
por: Moreira, Nádia das Dores, et al.
Publicado: (2012)

Clinical, hematological and biochemical alterations in hamster (Mesocricetus auratus) experimentally infected with Leishmania infantum through different routes of inoculation
por: Moreira, Nádia das Dores, et al.
Publicado: (2016)

Chimeric Vaccines Designed by Immunoinformatics-Activated Polyfunctional and Memory T cells that Trigger Protection against Experimental Visceral Leishmaniasis
por: De Brito, Rory Cristiane Fortes, et al.
Publicado: (2020)

A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden
por: Roatt, Bruno Mendes, et al.
Publicado: (2017)

The TcI and TcII Trypanosoma cruzi experimental infections induce distinct immune responses and cardiac fibrosis in dogs
por: Duz, Ana Luiza Cassin, et al.
Publicado: (2014)

LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4(+) and CD8(+)) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis
por: Aguiar-Soares, Rodrigo Dian de Oliveira, et al.
Publicado: (2014)

Generation of Luciferase-Expressing Leishmania infantum chagasi and Assessment of Miltefosine Efficacy in Infected Hamsters through Bioimaging
por: Reimão, Juliana Q., et al.
Publicado: (2015)

Effect of Clindamycin on Intestinal Microbiome and Miltefosine Pharmacology in Hamsters Infected with Leishmania infantum
por: Olías-Molero, Ana Isabel, et al.
Publicado: (2023)

Dogs immunized with LBSap vaccine displayed high levels of IL-12 and IL-10 cytokines and CCL4, CCL5 and CXCL8 chemokines in the dermis
por: Vitoriano-Souza, Juliana, et al.
Publicado: (2013)

LBMPL Vaccine Therapy Induces Progressive Organization of the Spleen Microarchitecture, Improved Th1 Adaptative Immune Response and Control of Parasitism in Leishmania infantum Naturally Infected Dogs
por: Roatt, Bruno Mendes, et al.
Publicado: (2022)

Alginate nanoparticles as non-toxic delivery system for miltefosine in the treatment of candidiasis and cryptococcosis
por: Spadari, Cristina de Castro, et al.
Publicado: (2019)

In vitro Infectivity of Strains Isolated From Dogs Naturally Infected With Leishmania infantum Present a Distinct Pathogenic Profile in Hamsters
por: Resende, Lucilene Aparecida, et al.
Publicado: (2020)

Immunosuppression of Syrian golden hamsters accelerates relapse but not the emergence of resistance in Leishmania infantum following recurrent miltefosine pressure
por: Hendrickx, S., et al.
Publicado: (2018)

Nanocarriers Provide Sustained Antifungal Activity for Amphotericin B and Miltefosine in the Topical Treatment of Murine Vaginal Candidiasis
por: de Bastiani, Fernanda Walt Mendes da Silva, et al.
Publicado: (2020)

No evidence for cardiotoxicity of miltefosine()
por: Dorlo, Thomas P.C.
Publicado: (2022)

Miltefosine enhances infectivity of a miltefosine-resistant Leishmania infantum strain by attenuating its innate immune recognition
por: Bulté, Dimitri, et al.
Publicado: (2021)

Detoxification of LTA by intracanal medication: analysis by macrophages proinflammatory cytokines production
por: de Oliveira, Luciane Dias, et al.
Publicado: (2022)

High loads of nano-hydroxyapatite/graphene nanoribbon composites guided bone regeneration using an osteoporotic animal model
por: Oliveira, Francilio Carvalho, et al.
Publicado: (2019)

No evidence for cardiotoxicity of miltefosine – Reply()
por: Barroso, Daniel Holanda, et al.
Publicado: (2022)

Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis
por: Ferreira, Carolina, et al.
Publicado: (2020)

Anterior Cruciate and Anterior Oblique Ligament Reconstruction Using Hamstrings and Peroneus Longus’ Anterior Half Grafts
por: Jorge, Pedro Baches, et al.
Publicado: (2023)

Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol
por: Gonçalves, Gustavo, et al.
Publicado: (2021)

Development of an immunogen containing CD4(+)/CD8(+) T-cell epitopes for the prophylaxis of tegumentary leishmaniasis
por: de Andrade Ferraz, Isabela, et al.
Publicado: (2022)

Oral miltefosine for refractory Acanthamoeba keratitis
por: Hirabayashi, Kristin E., et al.
Publicado: (2019)

Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine
por: Lu, Lu, et al.
Publicado: (2020)

Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis
por: Peixoto, Fábio, et al.
Publicado: (2020)

Clinical Forms of Canine Visceral Leishmaniasis in Naturally Leishmania infantum–Infected Dogs and Related Myelogram and Hemogram Changes
por: Nicolato, Roney de Carvalho, et al.
Publicado: (2013)

Delirium rating scales in critically ill patients: a systematic literature review
por: Carvalho, João Pedro Lins Mendes, et al.
Publicado: (2013)

Dynamics of Parasite Clearance in Cutaneous Leishmaniasis Patients Treated with Miltefosine
por: Dorlo, Thomas P. C., et al.
Publicado: (2011)

Evaluation of Immunoprotective Activity of Six Leptospiral Proteins in the Hamster Model of Leptospirosis
por: Atzingen, Marina V, et al.
Publicado: (2012)

Performance of LBSap Vaccine after Intradermal Challenge with L. infantum and Saliva of Lu. longipalpis: Immunogenicity and Parasitological Evaluation
por: Roatt, Bruno Mendes, et al.
Publicado: (2012)

Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs
por: Giunchetti, Rodolfo Cordeiro, et al.
Publicado: (2007)

Leishmania Resistance to Miltefosine Associated with Genetic Marker
por: Cojean, Sandrine, et al.
Publicado: (2012)

SUCCESSFUL TREATMENT OF MULTIFOCAL CUTANEOUS LEISHMANIASIS WITH MILTEFOSINE
por: Madke, Bhushan, et al.
Publicado: (2011)

Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis
por: Castro, María del Mar, et al.
Publicado: (2017)

Effects of homologous and heterologous rich platelets plasma, compared to poor platelets plasma, on cutaneous healing of rabbits
por: Meira, Raquel de Oliveira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o264dqqlvgdjt97qkfdvogqs1v